Right now, Amyris has commercialized 13 different molecules using biotechnology, including some that are licensed exclusively to fragrance partners, Tsong said, as well as some that are used medically, like malaria medication Artemisinin. Amyris has also created CBG, cannabigerol, and is working on "bio silica" from its sugarcane waste stream, she added.